Adult-onset manifestation of idiopathic T-cell lymphopenia due to a heterozygous RAG1 mutation - 29/04/13
Disclosure of potential conflict of interest: R. S. Abraham has received one or more payments for travel/accommodations/meeting expenses from the Clinical Immunology Society. F. Frugoni is employed by Children’s Hospital Boston. Y. N. Lee is employed by Children’s Hospital Boston. L. D. Notarangelo has received one or more grants from or has one or more grants pending with the National Institutes of Health and the March of Dimes; is employed by Children’s Hospital Boston; is a Board member for the Immune Disease Institute; has received payments for lecturing and for travel/accommodations/meeting expenses from USIDNET; and has received royalties from UpToDate. M. Recher has been supported by one or more grants from the Swiss National Science Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 131 - N° 5
P. 1421-1423 - mai 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?